Search research articles
Contact Us
Filters
Showing results (131-140 of 263) with videos related to
Page
of 27
Sort By:
Antiviral Therapy
|
August 1, 1996
Short-term anti-HIV activity of the combination of didanosine and hydroxyurea
B Clotet, L Ruiz, C Cabrera, et al.
Antiviral Therapy
|
December 1, 1996
Plasma HIV-1 RNA as a predictor of the efficacy of adding zalcitabine to a previous regimen with zidovudine
L Ruiz, J Romeu, A Ibáñez, et al.
Lancet (London, England)
|
May 19, 1990
Hospital outbreak of scabies stemming from two AIDS patients with Norwegian scabies
G Sirera, F Rius, J Romeu, et al.
Journal of Medical Virology
|
February 15, 2001
Primary HIV-1 drug resistance in Spain before and after the introduction of protease inhibitors
M Pérez-Olmeda, J Del Romero, A Rubio, et al.
AIDS (London, England)
|
October 2, 2001
Psychological impact of structured treatment interruptions in patients with prolonged undetectable HIV-1 viral loads
A Tuldrà, C R Fumaz, M J Ferrer, et al.
Epidemiology and Infection
|
October 31, 2002
Initiation, changes in use and effectiveness of highly active anti-retroviral therapy in a cohort of injecting drug users
J M Egea, R Muga, G Sirera, et al.
Medicina Clinica
|
February 25, 1984
[Sternoclavicular arthritis caused by Staphylococcus aureus in a non-drug addicted adult]
B Clotet-Sala, A Martínez-Vea, A Cuxart, et al.
AIDS (London, England)
|
May 1, 1991
Twice-weekly dapsone-pyrimethamine for preventing PCP and cerebral toxoplasmosis
B Clotet, G Sirera, J Romeu, et al.
Antiviral Therapy
|
May 7, 2003
Evolution of genotypic resistance to nucleoside analogues in patients receiving protease inhibitor-containing regimens
M Pèrez-Olmeda, A Rubio, T Puig, et al.
The American Journal of Gastroenterology
|
December 1, 1988
Spontaneous resolution of Candida esophagitis in a seroconverting patient for HIV antibodies
B Clotet, J Romeu, A Casals, et al.
Page
of 27
Search research articles
Search
Showing results (131-140 of 263) with videos related to
Sort By:
Page
of 27
Antiviral Therapy
|
August 1, 1996
Short-term anti-HIV activity of the combination of didanosine and hydroxyurea
B Clotet, L Ruiz, C Cabrera, et al.
Antiviral Therapy
|
December 1, 1996
Plasma HIV-1 RNA as a predictor of the efficacy of adding zalcitabine to a previous regimen with zidovudine
L Ruiz, J Romeu, A Ibáñez, et al.
Lancet (London, England)
|
May 19, 1990
Hospital outbreak of scabies stemming from two AIDS patients with Norwegian scabies
G Sirera, F Rius, J Romeu, et al.
Journal of Medical Virology
|
February 15, 2001
Primary HIV-1 drug resistance in Spain before and after the introduction of protease inhibitors
M Pérez-Olmeda, J Del Romero, A Rubio, et al.
AIDS (London, England)
|
October 2, 2001
Psychological impact of structured treatment interruptions in patients with prolonged undetectable HIV-1 viral loads
A Tuldrà, C R Fumaz, M J Ferrer, et al.
Epidemiology and Infection
|
October 31, 2002
Initiation, changes in use and effectiveness of highly active anti-retroviral therapy in a cohort of injecting drug users
J M Egea, R Muga, G Sirera, et al.
Medicina Clinica
|
February 25, 1984
[Sternoclavicular arthritis caused by Staphylococcus aureus in a non-drug addicted adult]
B Clotet-Sala, A Martínez-Vea, A Cuxart, et al.
AIDS (London, England)
|
May 1, 1991
Twice-weekly dapsone-pyrimethamine for preventing PCP and cerebral toxoplasmosis
B Clotet, G Sirera, J Romeu, et al.
Antiviral Therapy
|
May 7, 2003
Evolution of genotypic resistance to nucleoside analogues in patients receiving protease inhibitor-containing regimens
M Pèrez-Olmeda, A Rubio, T Puig, et al.
The American Journal of Gastroenterology
|
December 1, 1988
Spontaneous resolution of Candida esophagitis in a seroconverting patient for HIV antibodies
B Clotet, J Romeu, A Casals, et al.
Page
of 27